PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS
Australia
2016238894
Filed on 2016-10-06
2016238894
Filed on 2016-10-06
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Singapore
11201604868Y
Filed on 2014-12-16
11201604868Y
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Mexico
MX/a/2016/007726
Filed on 2014-12-16
MX/a/2016/007726
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
South Korea
10-2016-7019097
Filed on 2014-12-16
10-2016-7019097
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
India
201617023312
Filed on 2014-12-16
201617023312
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Hong Kong
17105504.9
Filed on 2017-06-02
17105504.9
Filed on 2017-06-02
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
China
201480074163.2
Filed on 2014-12-16
201480074163.2
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Brazil
BR112016013804-0
Filed on 2014-12-16
BR112016013804-0
Filed on 2014-12-16
MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE
Patent Cooperation Treaty
PCT/US2016/052496
Filed on 2016-09-19
PCT/US2016/052496
Filed on 2016-09-19